HENCER FUFANG DILONG JIAONANG For Cerebrovascular Disease 0.28g*24 Capsules

(No reviews yet) Write a Review
US $33.99
SKU:
B0338
Shipping:
Calculated at Checkout
Origin:
China
Form:
Capsules
Adding to cart… The item has been added

Product Overview

Generic name: Compound Dilong Capsule
Chinese Pinyin: FuFangDiLongJiaoNang
Product name: HENCER
Ingredients: Dilong (fresh), Chuanxiong, Astragalus, Achyranthes.
Properties: This product is a capsule, the content is light yellow to brownish yellow powder; the taste is slightly sweet.
Functions and indications: To remove blood stasis and dredge collaterals, replenish qi and activate blood circulation. It is used for Qi deficiency and blood stasis syndrome in the recovery period of meridian in ischemic stroke. Symptoms of hemiplegia, chewing of the tongue, astringent or silent speech, numbness, fatigue, palpitations, shortness of breath, salivation, spontaneous sweating, etc.
Specification: 0.28g*24 capsules/box
Usage and dosage: Orally, 2 capsules at a time, 3 times a day, after meals.
Adverse reactions: Individual patients experience stomach discomfort after taking the medicine for 2 to 3 days.
Contraindications: Not suitable for people with phlegm-heat syndrome, fire-stagnation syndrome, stasis-heat syndrome and other heat signs.
Note: Not yet clear
Pharmacology and Toxicology: 1. Animal experiments show that this product can reduce the cerebral infarction area of ​​rats caused by middle cerebral artery ligation, increase cerebral blood flow in anesthetized dogs, reduce vascular resistance, and prolong the time of thrombosis in rats.
2. Reduce the adhesion rate of platelets, reduce blood viscosity, and reduce fibrinogen content.
3. It can significantly increase the ratio of high density protein, high density lipoprotein and low density lipoprotein.
Storage: Sealed, protected from light, and kept in a cool (not exceeding 20℃) dry place.
Packaging: Aluminum-plastic packaging, 12 tablets/board*2board/box.
Validity period: 24 months
Executive standard: National Drug Standards of the State Food and Drug Administration (New Drugs Standards) WS3-569 (Z-114)-2002 (Z)
Approval number: National Medicine Zhunzi Z19991007
Company Name: Nanjing Hengsheng Pharmaceutical Co., Ltd.
Company Address: No. 18, Airport Road, Economic Development Zone, Lishui County, Nanjing

Reviews

(No reviews yet) Write a Review